Rapaport; Eliezer

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rapaport; Eliezer.The latest application filed is for "methods and compositions of [32p]-labeled adenine nucleotides for the treatment of atherosclerosis, vascular arterial diseases and coronary artery diseases".

Company Profile

0.8.5

Rapaport; Eliezer - Belmont MA
Rapaport; Eliezer - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions of [32P]-labeled adenine nucleotides for the treatment of atherosclerosis, vascular arterial diseases and coronary artery diseases Grant 8,303,934 - Rapaport November 6, 2	2012-11-06
Methods And Compositions Of [32p]-labeled Adenine Nucleotides For The Treatment Of Atherosclerosis, Vascular Arterial Diseases And Coronary Artery Diseases App 20120128582 - Rapaport; Eliezer	2012-05-24
Methods and therapeutic compositions in the treatment of advanced cancer Grant 7,879,814 - Rapaport February 1, 2	2011-02-01
Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides Grant 7,671,038 - Rapaport March 2, 2	2010-03-02
Methods and therapeutic compositions for improving liver, blood flow and skeletal muscle functions in advanced diseases and aging App 20070203091 - Rapaport; Eliezer	2007-08-30
Methods and therapeutic compositions in the treatment of advanced cancer App 20050079225 - Rapaport, Eliezer	2005-04-14
Methods, pharmaceutical and therapeutic compositions for administering adenosine App 20040162264 - Rapaport, Eliezer	2004-08-19
Methods, pharmaceutical and therapeutic compostions for administering adenosine Grant 6,723,737 - Rapaport April 20, 2	2004-04-20
Methods and therapeutic compositions for utilization of adenosine 5'-triphosphate (ATP) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) App 20030109486 - Rapaport, Eliezer	2003-06-12
Oligonucleotides active against drug-resistant bacteria Grant 6,335,436 - Rapaport , et al. January 1, 2	2002-01-01
Antiparasitic oligonucleotides active against drug resistant malaria Grant 5,616,564 - Rapaport , et al. April 1, 1	1997-04-01
Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels Grant 5,049,372 - Rapaport * September 17, 1	1991-09-17
Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate Grant 4,880,918 - Rapaport November 14, 1	1989-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.